Population pharmacokinetic analysis from phase I and phase II studies of the humanized monovalent antibody, MetMAb, in patients with advanced solid tumors.
S. Bai
No relevant relationships to disclose
Y. Xin
No relevant relationships to disclose
D. Jin
No relevant relationships to disclose
S. Kaur
No relevant relationships to disclose
I. Nijem
No relevant relationships to disclose
J. G. Bothos
No relevant relationships to disclose
A. C. Peterson
No relevant relationships to disclose
P. H. Patel
No relevant relationships to disclose